The utility of [11C] dihydrotetrabenazine positron emission tomography scanning in assessing β-cell performance after sleeve gastrectomy and duodenal-jejunal bypass

Surgery

Volumn 147, Issue 2, 2010, Pages 303-309

  Inabnet, William B ^a   Milone, Luca ^b   Harris, Paul ^b   Durak, Evren ^b   Freeby, Matthew J ^b   Ahmed, Leaque ^b   Sebastian, Manu ^b   Lifante, Jean Christophe ^b   Bessler, Marc ^b   Korner, Judith ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROTETRABENAZINE C 11; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DUODENUM; GASTRECTOMY; GLUCOSE HOMEOSTASIS; GOTO KAKIZAKI RAT; INSULIN BLOOD LEVEL; INTESTINE BYPASS; JEJUNUM; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; RAT; WEIGHT GAIN;

ANIMALS; BARIATRIC SURGERY; CARBON RADIOISOTOPES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DUODENUM; GASTRECTOMY; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; JEJUNUM; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, INBRED STRAINS; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 74149094882     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.08.005     Document Type: Article

References (23)

1. Hossain P., Kawar B., and El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 356 (2007) 213-215
2. Flegal K.M., Carroll M.D., Kuczmarski R.J., and Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22 (1998) 39-47
3. Kral J.G. Morbidity of severe obesity. Surg Clin North Am 81 (2001) 1039-1061
4. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
5. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-350
6. Ponce J., Haynes B., Paynter S., et al. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 14 (2004) 1335-1342
7. Torquati A., Lutfi R., Abumrad N., and Richards W.O. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?. J Gastrointest Surg 9 (2005) 1112-1116
8. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
9. Dixon J.B., O'Brien P.E., Playfair J., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299 (2008) 316-323
10. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238 (2003) 467-484
11. Simpson N.R., Souza F., Witkowski P., et al. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33 (2006) 855-864
12. Souza F., Simpson N., Raffo A., et al. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 116 (2006) 1506-1513
13. Rubino F., and Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239 (2004) 1-11
14. Conybeare G., and Leslie G.B. Improved oral dosing technique for rats. J Pharmacol Methods 19 (1988) 109-116
15. Inabnet III W.B., Milone L., Korner J., et al. A rodent model of metabolic surgery for study of type 2 diabetes and positron emission tomography scanning of beta cell mass. Surg Obes Relat Dis 5 (2009) 212-217
16. Pacheco D., de Luis D.A., Romero A., et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 194 (2007) 221-224
17. Rubino F., Forgione A., Cummings D.E., et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244 (2006) 741-749
18. Drucker D.J., and Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 (2006) 1696-1705
19. Korner J., Bessler M., Inabnet W., et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3 (2007) 597-601
20. Melissas J., Koukouraki S., Askoxylakis J., et al. Sleeve gastrectomy: a restrictive procedure?. Obes Surg 17 (2007) 57-62
21. Ilias I., Chen C.C., Carrasquillo J.A., et al. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 49 (2008) 1613-1619
22. Movassat J., Calderari S., Fernandez E., et al. Type 2 diabetes-a matter of failing beta-cell neogenesis? Clues from the GK rat model. Diabetes Obes Metab 9 Suppl 2 (2007) 187-195
23. Momose K., Nunomiya S., Nakata M., et al. Immunohistochemical and electron-microscopic observation of beta-cells in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats. Med Mol Morphol 39 (2006) 146-153